BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35737446)

  • 1. RREB1 promotes the development of parafollicular carcinogenesis through the Ras-Raf-1-ELK3 signaling pathway.
    Ma S; Wang H; Li W; Yan Z; Luo X; Lu P
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):972-981. PubMed ID: 35737446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.
    Song H; Lin C; Yao E; Zhang K; Li X; Wu Q; Chuang PT
    J Biol Chem; 2017 Mar; 292(9):3888-3899. PubMed ID: 28119454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid C-Cell Biology and Oncogenic Transformation.
    Cote GJ; Grubbs EG; Hofmann MC
    Recent Results Cancer Res; 2015; 204():1-39. PubMed ID: 26494382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice.
    Starenki D; Singh NK; Jensen DR; Peterson FC; Park JI
    Cancer Lett; 2013 Oct; 339(1):144-51. PubMed ID: 23856028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS proto-oncogene in medullary thyroid carcinoma.
    Moura MM; Cavaco BM; Leite V
    Endocr Relat Cancer; 2015 Oct; 22(5):R235-52. PubMed ID: 26285815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Wang Y; Du LL; Hou SH; Han CZ; Zhao XW; Wang WG; Xu XQ; Jing JX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):873-876. PubMed ID: 27938622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary thyroid carcinoma: a narrative historical review.
    Wong A; Nabata K; Wiseman SM
    Expert Rev Anticancer Ther; 2022 Aug; 22(8):823-834. PubMed ID: 35694971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Medullary Thyroid Carcinoma Arise in Thyroglossal Duct Cysts? A Search for Parafollicular C-cells in 41 Resected Cases.
    Stein T; Murugan P; Li F; El Hag MI
    Head Neck Pathol; 2018 Mar; 12(1):71-74. PubMed ID: 28536894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion.
    Giardino E; Catalano R; Mangili F; Barbieri AM; Treppiedi D; Elli FM; Dolci A; Contarino A; Spada A; Arosio M; Mantovani G; Peverelli E
    Mol Cell Endocrinol; 2021 Jan; 520():111092. PubMed ID: 33248230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation.
    Carson EB; McMahon M; Baylin SB; Nelkin BD
    Cancer Res; 1995 May; 55(10):2048-52. PubMed ID: 7743500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.
    Nakagawa T; Mabry M; de Bustros A; Ihle JN; Nelkin BD; Baylin SB
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5923-7. PubMed ID: 3112776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium is a biased agonist of the calcium-sensing receptor in rat medullary thyroid carcinoma 6-23 cells.
    Thomsen AR; Worm J; Jacobsen SE; Stahlhut M; Latta M; Bräuner-Osborne H
    J Pharmacol Exp Ther; 2012 Dec; 343(3):638-49. PubMed ID: 22942242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
    Park JI; Strock CJ; Ball DW; Nelkin BD
    Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
    Alapat DV; Ain KB; Sloan DA; Monaghan KG; Karabakhtsian RG
    Endocrine; 2011 Apr; 39(2):148-52. PubMed ID: 21243446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
    Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
    Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.
    Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F
    Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary thyroid cancer - An update.
    Fugazzola L
    Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101655. PubMed ID: 35422397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
    Arthan D; Hong SK; Park JI
    Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
    Kim EJ; Park JI; Nelkin BD
    J Biol Chem; 2005 Feb; 280(6):4913-20. PubMed ID: 15572361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.